Compare Ginkgo Bioworks Holdings Inc (DNA) vs Logitech International SA (LOGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Logitech International SA — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Logitech International SA trades at $98.27 (market cap $14.46B). The key difference: Logitech International SA is far larger — about 18.9× Ginkgo Bioworks Holdings Inc's market cap, and Logitech International SA pays a 1.63% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Logitech International SA for 92 Days on average.
| DNA | LOGI | |
|---|---|---|
Market Cap | $763.64M | $14.46B |
Volume | 3,204,177 | 349,547 |
Sector | Health | Technology |
52-Week High | $15.83 | $126.69 |
52-Week Low | $5.48 | $85.84 |
Typical Hold Time | 7 Days | 92 Days |
Enterprise Value | $865.59M | $12.79B |
Dividend Yield | — | 1.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
Logitech (LOGI) trades at $101.50, down 0.67% on the day, with neutral technical indicators and mixed analyst sentiment. The company demonstrates strong profitability with 45.13% gross margins and 35.29% ROE, while recent earnings beats and new product launches including Zone Vibe Pro headsets and gaming partnerships signal innovation momentum. Cash flow trends show operational strength despite recent net outflow.
Outlook remains balanced with 5.3% upside to consensus price target of $107, though analyst ratings are evenly split. Key risks include chip shortage challenges cited by management and competitive pressures in the peripheral market. Revenue growth acceleration to $4.9B projected for 2026 supports potential valuation expansion if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
